Preventive capacity of subcutaneous immunotherapy

Current Opinion in Allergy and Clinical Immunology

Volumn 2, Issue 6, 2002, Pages 553-556

  Valovirta, Erkka ^a  

^a Turku Allergy Center   (Finland)

Author keywords

Allergen specific injection immunotherapy; Asthma; Prevention; Sensitisation

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; POLLEN ANTIGEN;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; ANTIGEN SPECIFICITY; CLINICAL EXAMINATION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; REMISSION; REVIEW; SENSITIZATION;

ASTHMA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN E; INJECTIONS, SUBCUTANEOUS; MALE; PRIMARY PREVENTION; RHINITIS, ALLERGIC, PERENNIAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036959109     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200212000-00013     Document Type: Review

References (27)

1. Johansson SGO, Haahtela T, editors, Prevention of allergy and asthma interim report. Allergy 2000; 55:1069-1088.
2. Malling HJ, Weeke B. Immunotherapy: position paper of the European Academy of Allergology and Clinical Immunology. Allergy 1993; 48 (Suppl 14):9-35.
3. Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. WHO position paper. Allergy 1998; 53 (Suppl 44):1-42.
4. Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. EAACI. Allergy 2000; 55:116-134.
5. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children: a 14-year study. Pediatrics 1968; 42:793-802.
6. Allergic rhinitis and its impact on asthma. ARIA workshop report. J Allergy Clin Immunol 2001; 108 (Suppl):147-336. This paper is a comprehensive consensus statement of the World Health Organization. The recommendations are based on the review of the literature by the methods of evidence-based medicine.
7. Togias A. Mechanisms of nose-lung interaction. Allergy 1999; 54 (Suppl):94-105.
8. Simons FE. Allergic rhinobronchitis: the asthma-allergic link. J Allergy Clin Immunol 1999; 104:534-540.
9. Pedersen PA, Weeke ER. Asthma and allergic rhinitis in the same patients. Allergy 1983; 38:25-29.
10. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994; 15:21-25.
11. Braman SS, Barrows AA, DeCotiis BA, et al. Airway hyperresponsiveness in allergic rhinitis: a risk factor for asthma. Chest 1987; 91:671-674.
12. Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997; 99 (Suppl):781-786.
13. Bauer CP, Untersuchung zur Asthmaprävention durch die specifische Immuntherapie bei Kindern [in German], Study of preventing the development of asthma during childhood with specific immunotherapy. Allergologie 1993:468.
14. Grembiale RD, Camporota L, Naty S, et al. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 162:2048-2052.
15. Walker SM, Pajno GB, Torres Lima M, et al. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001; 107:87-93. Important study showing the efficacy of immunotherapy in allergic rhinitis and seasonal asthma. The results also show the increase in the quality of life of the patients receiving immunotherapy.
16. Jacobsen L, Nuchel Petersen B, Wihl JÅ, et al. Immunotherapy with partially purified and standardized tree pollen extracts. IV: Results from long-term (6-year) follow-up. Allergy 1997; 52:914-920.
17. Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109:251-256. An important multi-centre study showing the preventive capacity of subcutaneous injection immunotherapy in reducing the risk of asthma in children with allergic rhinitis and allergy to birch or timothy pollen.
18. Rak S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988; 82:470-480.
19. Hamid QA, Schotman E, Jacobson MR, et al. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy. J Allergy Clin Immunol 1997; 99:254-260.
20. Ebner C, Siemann U, Bohle B, et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from Th2 to Thl in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997; 27:1007-1015.
21. Des Roches A, Paradis L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, VI: Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99:450-453.
22. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to immunotherapy or not: a retrospective study. Clin Exp Allergy 2001; 31:1295-1302.
23. Pajno GB, Barberio G, De Luca FR, et al. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy: a six year follow-up study. Clin Exp Allergy 2001; 31:1392-1397.
24. Walker SM, Varney VA, Gaga M, et al. Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study. Allergy 1995; 50:405-413.
25. Van Hage-Hamsten M, Valenta R. Specific immunotherapy: the induction of new IgE-specificities? [editorial]. Allergy 2002; 57:375-378. Important editorial discussing the quality of allergens and allergen extracts in the diagnosis and treatment of allergic diseases.
26. Moverare R, Elfman L, Vesterinen E, et al. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002; 57:423-430.
27. Ball T, Sperr WR, Valent P, et al. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol 1999; 29:2026-2036.